Drug
ET-26
ET-26 is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
2
67%
Ph phase_3
1
33%
Phase Distribution
2
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
Phase 3Large-scale testing
1(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Other(2)
Detailed Status
unknown2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 12 (66.7%)
Phase 31 (33.3%)
Trials by Status
completed133%
unknown267%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_1
Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride
NCT06822166
unknownphase_3
A Trial to Evaluate the Efficacy and Safety of Methoxyetomidate Hydrochloride for Injection (ET-26) for the Induction of General Anesthesia in Elective Surgery Subjects
NCT06203431
unknownphase_1
Phase 1 Hepatic Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride
NCT06176716
Clinical Trials (3)
Showing 3 of 3 trials
NCT06822166Phase 1
Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride
NCT06203431Phase 3
A Trial to Evaluate the Efficacy and Safety of Methoxyetomidate Hydrochloride for Injection (ET-26) for the Induction of General Anesthesia in Elective Surgery Subjects
NCT06176716Phase 1
Phase 1 Hepatic Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3